These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 535604)

  • 21. In vitro chemosensitivity tests on xenografted human melanomas.
    Bateman AE; Selby PJ; Steel GG; Towse GD
    Br J Cancer; 1980 Feb; 41(2):189-98. PubMed ID: 7370159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of two in vitro assays of cell response following in vitro drug and radiation exposures of human tumour xenograft cells.
    Hanson JA; Bean EA; Coombs AM; Moore JL
    Br J Cancer; 1985 Oct; 52(4):637-40. PubMed ID: 4063141
    [No Abstract]   [Full Text] [Related]  

  • 23. [A study of the combined effect of antitumorous alkylating agents and vitamin B 12 on a model of a metastasizing tumor].
    Miuller NR
    Vopr Onkol; 1966 Apr; 12(4):69-74. PubMed ID: 4971005
    [No Abstract]   [Full Text] [Related]  

  • 24. Changes in distribution of the phases of mitosis in human tumor xenografts following drug treatment.
    Siracký J; Sparrow S; Jones M
    Neoplasma; 1984; 31(5):539-44. PubMed ID: 6504212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Value of xenografts in the investigation of prostatic function: preliminary communication.
    Jones MA; Williams G; Davies AJ
    J R Soc Med; 1980 Oct; 73(10):708-12. PubMed ID: 7241424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Verotoxin sensitivity of ECV304 cells in vitro and in vivo in a xenograft tumour model: VT1 as a tumour neovascular marker.
    Heath-Engel HM; Lingwood CA
    Angiogenesis; 2003; 6(2):129-41. PubMed ID: 14739619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ability of CEA blood levels to reflect tumour burden: a study in a human xenograft model.
    Quayle JB
    Br J Cancer; 1982 Aug; 46(2):220-7. PubMed ID: 7150474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Melphalan: a potential new agent in the treatment of childhood rhabdomyosarcoma.
    Houghton JA; Cook RL; Lutz PJ; Houghton PJ
    Cancer Treat Rep; 1985 Jan; 69(1):91-6. PubMed ID: 3967262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Radiobiological analysis of the antineoplastic action of sarcolysine].
    Iarmonenko SP; Syrkin AB; Solenov VN
    Med Radiol (Mosk); 1982 May; 27(5):66. PubMed ID: 6808283
    [No Abstract]   [Full Text] [Related]  

  • 30. Reduction of tumour intracellular pH and enhancement of melphalan cytotoxicity by the ionophore Nigericin.
    Wood PJ; Sansom JM; Newell K; Tannock IF; Stratford IJ
    Int J Cancer; 1995 Jan; 60(2):264-8. PubMed ID: 7829226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemosensitivity studies on human tumour cells from a pancreatic carcinoma xenograft.
    Smith IE
    J R Soc Med; 1979 Apr; 72(4):260-3. PubMed ID: 552510
    [No Abstract]   [Full Text] [Related]  

  • 32. Proceedings: An "in vitro" colony assay for human humours: radiation survival in a pancreatic tumour xenograft.
    Courtenay VD; Mills J
    Br J Radiol; 1976 Jun; 49(582):558. PubMed ID: 1276633
    [No Abstract]   [Full Text] [Related]  

  • 33. Adenosine 3',5'-monophosphate phosphodiesterase activity in experimental animal tumours which are either sensitive or resistant to bifunctional alkylating agents.
    Tisdale MJ; Phillips BJ
    Biochem Pharmacol; 1975 Jan; 24(2):205-10. PubMed ID: 163093
    [No Abstract]   [Full Text] [Related]  

  • 34. Attempted targeting of a monoclonal antibody in a human tumour xenograft system.
    Warenius HM; Galfre G; Bleehen NM; Milstein C
    Eur J Cancer Clin Oncol; 1981 Sep; 17(9):1009-15. PubMed ID: 7198983
    [No Abstract]   [Full Text] [Related]  

  • 35. Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer.
    Von Marschall Z; Scholz A; Stacker SA; Achen MG; Jackson DG; Alves F; Schirner M; Haberey M; Thierauch KH; Wiedenmann B; Rosewicz S
    Int J Oncol; 2005 Sep; 27(3):669-79. PubMed ID: 16077915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accurate prediction of experimental cancer chemosensitivity using the subrenal capsule xenograft assay.
    Bennett JA; Pilon VA; Uppal GS; McKneally MF
    J Surg Oncol; 1986 Sep; 33(1):8-13. PubMed ID: 3762179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo anti-tumour activity of FCE 23762, a methoxymorpholinyl derivative of doxorubicin active on doxorubicin-resistant tumour cells.
    Ripamonti M; Pezzoni G; Pesenti E; Pastori A; Farao M; Bargiotti A; Suarato A; Spreafico F; Grandi M
    Br J Cancer; 1992 May; 65(5):703-7. PubMed ID: 1586598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potentiation of melphalan activity against a murine tumour by nitroimidazole compounds.
    Sheldon PW; Batten EL; Adams GE
    Br J Cancer; 1982 Oct; 46(4):525-31. PubMed ID: 7138761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brief communication: metastases of human melanomas transplanted in "nude" mice.
    Giovanella BC; Yim SO; Morgan AC; Stehlin JS; Williams LJ
    J Natl Cancer Inst; 1973 Apr; 50(4):1051-3. PubMed ID: 4703769
    [No Abstract]   [Full Text] [Related]  

  • 40. Response of a high-glucuronidase human tumour xenograft to aniline mustard.
    Warenius HM; Workman P; Bleehen NM
    Br J Cancer; 1982 Jan; 45(1):27-34. PubMed ID: 7059462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.